PUBLICATION

Ligand/PTC-free intramolecular Heck reaction: synthesis of pyrroloquinoxalines and their evaluation against PDE4/luciferase/oral cancer cell growth in vitro and zebrafish in vivo

Authors
Babu, P.V., Mukherjee, S., Deora, G.S., Chennubhotla, K.S., Medisetti, R., Yellanki, S., Kulkarni, P., Sripelly, S., Parsa, K.V., Chatti, K., Mukkanti, K., and Pal, M.
ID
ZDB-PUB-130905-1
Date
2013
Source
Organic & biomolecular chemistry   11(39): 6680-5 (Journal)
Registered Authors
Chatti, Kiranam, Kulkarni, Pushkar
Keywords
none
MeSH Terms
  • Animals
  • Binding Sites
  • Catalysis
  • Cell Proliferation/drug effects
  • Embryo, Nonmammalian/drug effects
  • Enzyme Activation/drug effects
  • Humans
  • Ligands
  • Luciferases/metabolism
  • Molecular Structure
  • Mouth Neoplasms/drug therapy*
  • Phosphodiesterase 4 Inhibitors/chemical synthesis*
  • Phosphodiesterase 4 Inhibitors/chemistry
  • Phosphodiesterase 4 Inhibitors/pharmacology*
  • Quinoxalines/chemical synthesis*
  • Quinoxalines/chemistry
  • Quinoxalines/pharmacology*
  • Zebrafish/embryology
PubMed
23986357 Full text @ Org. Biomol. Chem.
Abstract

A series of 1,3-disubstituted pyrrolo[2,3-b]quinoxalines has been designed for the potential inhibition of PDE4 without inhibiting luciferase. A ligand/PTC (phase transfer catalyst) free intramolecular Heck cyclization strategy was used to prepare these compounds, some of which showed significant inhibition of PDE4B (IC50 H 5–14 μM) and growth inhibition of oral cancer cells (CAL 27) but not inhibition of luciferase in vitro. They also showed acceptable safety profiles but no apoptosis in zebrafish embryos.

Genes / Markers
Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping